The health risk information presented here is summarized from Shoreland Travax®, a decision-support tool used by health care providers to perform a detailed health risk analysis based on specific locations, individual travel styles, and traveler risk behaviors. Travax provides practitioners current, independently researched malaria risk and prevention recommendations in a map-based format that goes beyond the annual WHO and US CDC statements included here. Not included here are current reports from Travax of disease outbreaks or environmental events that may pose elevated risks to travelers’ health and safety. The Providers section of this site offers a directory of health care providers who utilize Shoreland Travax for travel health counseling. Learn more about the detailed reports and maps available from these practitioners (includes links to samples).
See also: COVID-19 Traveler Summary
Fully vaccinated: 15.1%
Daily new cases: 0 (7-day rolling average)
Daily new deaths: 0 (7-day rolling average)
No recommendation against travel to this country is in place. All travelers should be up-to-date on COVID-19 vaccinations prior to their trip and follow destination requirements and recommendations.
Djibouti is a developing nation classified as lower middle income. Located in eastern Africa along the Gulf of Aden and the Red Sea (north of Somalia), the climate is classified as predominantly dry (arid).
Depending on your itinerary, your personal risk factors, and the length of your visit, your health care provider may offer you vaccination against hepatitis A, hepatitis B, influenza, measles, mumps, rubella, rabies, typhoid fever, or a one time polio booster if you haven't previously received one for travel. Routine immunizations, such as those that prevent tetanus/diphtheria or "childhood" diseases, should be reviewed and updated as needed.
See also: Library article for Malaria
The following is current information as reported by the World Health Organization (WHO) and the US Centers for Disease Control (CDC):
WHO—International Travel and Health (current online update, Country List)(2021) Malaria risk due predominantly to P. falciparum exists throughout the year in the entire country.
- Recommended prevention: C – Risk of P. falciparum malaria, in combination with reported chloroquine and sulfadoxine–pyrimethamine resistance. Mosquito bite prevention plus atovaquone–proguanil or doxycycline or mefloquine chemoprophylaxis (select according to reported side effects and contraindications) a
aAlternatively, for travel to rural areas with low risk of malaria infection, mosquito bite prevention can be combined with stand–by emergency treatment (SBET).
WHO Country List footnote: When available, the date of the most recent update or confirmation is indicated in parentheses in the country list. If no date is indicated, the most recent update or confirmation was provided before 2013.
CDC—Health Information for International Travel (current online edition)Areas with malaria: All.
- Drug resistance3 : Chloroquine.
- Malaria species: P. falciparum 90%, P. vivax 5%–10%.
- Recommended chemoprophylaxis: Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine.4
3 Refers to P. falciparum malaria unless otherwise noted.
4 Primaquine and tafenoquine can cause hemolytic anemia in people with G6PD deficiency. Patients must be screened for G6PD deficiency before starting primaquine or tafenoquine. See Tafenoquine Approved for Malaria Prophylaxis and Treatment for more information.
See also: Library article for Travelers' Diarrhea
High risk exists throughout the country, including in deluxe accommodations. Food and beverage precautions may reduce the likelihood of illness.
Travelers should carry loperamide for self-treatment of diarrhea and, if risk is moderate to high, an antibiotic to add if diarrhea is severe. Consult a knowledgeable health care provider regarding which antibiotic is appropriate for you and most effective for your destination.
Insect- and Arthropod-Borne Diseases
Other Disease and Health Risks
The material below includes information from the US Department of State (DOS), the UK Foreign, Commonwealth & Development Office (FCO), Global Affairs Canada (GAC), and Australia's Department of Foreign Affairs and Trade (DFAT), as well as from additional open-source material. Standard safety precautions that apply to all international travel can be found in the Library article Safety and Security.
Consular Travel Advice
Due to military conflict, Australia (DFAT) advises avoiding travel to within 10 km (6.2 mi) of the border with Eritrea and 10 km (6.2 mi) of the border with Somalia. UK (FCO) and Canada (GAC) have more limited warnings. US (DOS) has no current warning.
Risk of attack by transnational terrorist groups exists throughout the country. Targets may include domestic and international organizations and businesses; public places and events, including those frequented by tourists; and transportation systems.
Negligible risk of violent crime exists throughout the country.
Moderate risk of petty crime exists throughout the country, especially in isolated locations, including Dorale and Khor Ambado beaches.
Protests and demonstrations may infrequently occur and have the potential to turn violent without warning. Bystanders are at risk of harm from violence or from the response by authorities. Disruption to transportation, free movement, or the ability to carry out daily activities may occur.
Armed conflict and territorial disputes may occur in areas bordering Eritrea. Landmines and other unexploded ordnance are present in areas bordering Ethiopia and Somalia. Unmarked boundaries exist in border areas. Piracy (involving commercial and private leisure vessels) may occur in coastal and international waters.
Rent water sports equipment from reputable operators. Scuba dive only with personnel certified by PADI or NAUI, and use equipment only from PADI- or NAUI-certified dive operators.
National incidence data on traffic-related injury or death are not available.
Extreme heat (which can lead to heat-related illness) occurs from May through October.
Seismic and volcanic activity frequently occurs.
Selected Embassies or Consulates in Djibouti
- United States: [+253] 21-45-30-00; dj.usembassy.gov
- Canada: [+253] 21-35-59-50; travel.gc.ca/assistance/embassies-consulates/djibouti
- United Kingdom: U.K. does not have an embassy or consulate in Djibouti.
- Australia: [+253] 21-35-38-44
Djibouti's Embassies or Consulates in Selected Countries
- In the U.S.: www.djiboutiembassyus.org
- In Canada: Djibouti does not have an embassy or consulate in Canada.
- In the U.K.: Djibouti does not have an embassy or consulate in the U.K.
- In Australia: Djibouti does not have an embassy or consulate in Australia.
HIV testing is not required to obtain a tourist, work, or residence visa.